As of Nov 24
| +0.94 / +3.05%|
The 10 analysts offering 12-month price forecasts for PTC Therapeutics Inc have a median target of 84.50, with a high estimate of 135.00 and a low estimate of 26.00. The median estimate represents a +166.14% increase from the last price of 31.75.
The current consensus among 10 polled investment analysts is to Buy stock in PTC Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.